CELLULAR effector mechanisms detectable in vitro during the growth of experimental tumours are heterogeneous. T cells, B cells and armed macrophages can express specific cytotoxicity in vitro against svngeneic target cells (Plata et al., 16973; Lamon et al., 1973; Evans and Alexander, 1970) .
Moreover, in addition to the specific effector mechanisms, non-specific cytotoxicity has been reported for lymphnode cells in rats bearing a chemically induced sarcoma (Currie and Gage, 1973) and in spleen cells of mice bearing virusinduced tumours (Kirchner, Holden and Herbermann, 1975a; Seeger, Rayner and Owen, 1974) . In the present investigation we have analysed the non-specific cellmediated inhibition of tumour cell DNA synthesis detectable in vitro during the growth of chemically induced fibrosarcomas transplanted into syngeneic mice.
MATERIALS AND METHODS
Animals.-CBA, C57BL and DBA/2 mice (8-10 weeks old) were used throughout.
Thymectomized, X-irradiated, bone-marrow-reconstituted (T-lymphocyte-deprived) CBA mice were provided by Dr A. J. S. Davies, and were prepared as previously described (Davies et al., 1969) . The absence of a thymus was checked at autopsy on the termination of the experiment.
Tumours.-The benzopyrene-induced FS6 and FS13 sarcomas were maintained by i.m. inoculation of 106 cells in the hind limb of syngeneic C57BL and CBA mice respectively. The tumours do not metastasize spontaneously and they kill the mice in 25-30 days. The SL2 and TLX9 lymphomas were maintained by i.p. passage in the syngeneic hosts, DBA/2 and C57BL mice respectively. Unless otherwise stated, mice (4-6 per experimental group) were used 15-20 days after tumour implantation. Surgical excision of the sarcomas was performed by amputating the * Present address: Istituto di Ricerche Farmacologiche "Mario Negri", Via Eritrea 62, 20157 Milano, Italy. affected limb. The tumours were cultivated in vitro in Medium RPMI 1640 containing 25 mm N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (Gibco-Biocult, Glasgow, Scotland), 50 ,ug/m] streptomycin, 50 i.u./ml penicillin and 10% foetal bovine serum (growth medium).
Spleen cells.-Spleens were minced with scissors in Medium 199 (Wellcome Research Laboratories, Beckenham, England) . After resuspension with a Pasteur pipette, the cells were washed twice with Medium 199 and finally resuspended in growth medium.
To kill T lymphocytes, spleen cells (107/ml) were incubated for 45 min with 1: 8 diluted AKR anti-6 serum (Searle) and 1: 10 diluted rat or guinea-pig serum as a source of complement (Reif and Allen, 1964) . The anti-0 serum employed for these studies killed > 90% thymocytes, < 5% bone-marrow cells and 25% splenocytes.
Phagocytic adherent cells were removed by the carbonyl-iron method (Lundgren, Zukoski and MolJer, 1968) . After treatment with carbonyl iron, the percentage of phagocytic elements assessed by neutral-red uptake was < 0500. Confirmation of their removal was provided by demonstrating that C. parvuminduced spleen macrophage cytotoxicity was abolished by this procedure, in agreement with previous reports (Kirchner, Holden and Herbermann, 1975b Amersham, England) . This washing procedure was critical to remove inhibitors which compete with 125JUdR during uptake by dividing cells (Evans and Booth, 1976) .
After incubation for 4 h, acid-precipitable radioactivity was determined in a well-type y-counter as previously described (Boyle and Ormerod, 1975) .
125IUdR uptake by appropriate spleen cells in the absence of tumour cells was subtracted, and percent inhibition of 125IUdR uptake calculated according to the formula:
where A is the radioactivity in the test group and B is the radioactivity incorporated by lymphoma cells in the absence of effector cells. It should be noted that no significant stimulation of DNA synthesis occurred when 2-5 x 106 C57BL spleen cells were incubated for 48 h with 0-8 x 106 X-irradiated (5000 rad) lymphoma cells. When fibrosarcoma cells were employed as targets, 5 x 104 tumour cells were incubated for 48 h w%rith splenocytes in Linbro plates (FM 16-24, Linbro Chemical Co., New Haven, Connecticut, U.S.A.). At the end of the incubation, the cells w%ere incubated for 20 min at 37°C with 0.1% trypsin in Medium 199 (Evans, 1973) , transferred to plastic tubes, -Nashed and pulsed as described above.
125JUdR-release assay.-TLX9 lymphoma cells were incubated for 16-20 h with 125IUdR (0 003 ,tCi/105 cells/ml) in growth medium.
After washing twice with 25 ml of Medium 199, 5 x 104 tumour cells were incubated for 24 or 48 h with 5 x 106 spleen cells in 195 ml of growth medium in plastic tubes. 125IUdR release was calculated according to the formula:
x 100 w"here a is the 125J in the supernatant and b is the isotope present in the cell pellet.
Statistical analysis. Splenocytes collected from these immune mice showed specific cytotoxicity for the FS6 tumour in the 125IUdR uptake assay (Table II) . Thus the lack of specificity observed in mice bearing actively growing tumours was not due to common antigenic determinants shared by the sarcomas and lymphomas used as targets for these studies.
TLX9 lymphoma cells were employed to characterize the non-specific inhibitory effect on target-cell DNA synthesis of FS6 As shown in Fig. 1 , in the presence of splenocytes from FS6 tumour-bearing mice, actual inhibition of tumour growth was observed.
When 125JUdR-prelabelled TLX9 lymphoma cells were cultivated in the presence of spleen cells from tumour-bearing mice, no significant degree of lysis could be detected over a period of up to 48 h (Table IV) . On the other hand, in parallel experiments marked inhibition of lymphoma DNA synthesis was observed, thus suggesting that non-specific cytotoxicity was the expression of a cytostatic reaction, and did not involve lysis of target cells. The time course for the appearance of nonspecific cytostasis was determined in C57BL mice transplanted with the FS6 tumour (Fig. 2) . No significant cytotoxicity was detectable on Day 7, when the tumour was just palpable and weighed about 02 g, but marked inhibition of TLX9 lymphoma DNA synthesis was observed on Day 15, and this remained at a constant level thereafter. Similar results were obtained with the FS 13 sarcoma (Fig. 3) . Surgical excision of the growing sarcomas on Day 7 prevented the appearance of non-specific cytostasis, while surgery on Day 15 resulted in complete disappearance of cytotoxicity by Day 30 (Figs 2 and 3) . In another series of experiments, the nature of effector cells involved in this non-specific cytotoxic reaction was investigated. As illustrated in Fig. 3 , T-lymphocyte-depleted CBA mice transplanted with the FS 13 fibrosarcoma showed cytotoxicity levels similar to those displayed by normal mice. Spleen cells obtained from nontumour-bearing T-cell-deprived CBA mice did not inhibit target-cell DNA synthesis. Treatment with anti-8 serum and comple- ment did not impair non-specific cytostasis, whereas removal of phagocytic cells with carbonyl iron markedly inhibited this activity (Table V) .
I)SCUSSION
The results )resented show that spleen cells collected from mice bearing transplanted chemically induced sarcomas nonspecifically inhibited both the DNA synthesis and growth of tumour cells in vitro. They confirm and extend previous observations in rats bearing chemically induced sarcomas (Currie and G-age, 1973) and in mice bearing virus-induced tumours (Seeger et al., 1974; Kirchner et al., 1975) . The non-specific cytostasis did not result in a significant degree of lysis of the target cells within 48 h. Since the TLX9 cells employed for these experiments were easily lysed by alloantibody and complement, or by alloimmune lymphocytes or macrophages, the failure of the spleen cells of tumour-bearers to cause lysis was not due to an inherent resistance of these lymphoma cells to lytic processes.
The non-specific cytotoxic activity of spleen cells from tumour-bearers was qualitatively different from that shown by spleen cells from hyperimmunized mice, since the latter was both specific and caused lysis. The effector cells responsible for the non-specific cytostasis probably belonged to the mononuclear phagocytic series, since T-lymphocyte-deprived mice showed no impairment of this cytotoxicity, and treatment with anti-6 serum and complement did not reduce the cytostasis of the spleen cells. Removal of phagocytic adherent cells by carbonyl iron markedly reduced but did not abolish cytotoxicity. The residual cytotoxicity following treatment of the cells with carbonyl iron might be due to macrophage precursors which do not spread and adhere rapidly (Meerpohl, Lohmann-Matthes and Fischer, 1976) .
Early surgical excision of the growing sarcomas prevented the development of non-specific cytostasis, and late removal of the tumour caused this activity to disappear. This finding, together with the observation that hyperimmunized splenocytes are specifically cytotoxic for the tumour employed for immunization, suggests that the presence of an actively growing tumour is a prerequisite for the expression of non-specific cytostasis. Macrophages from immune mice can be rendered non-specifically cytotoxic on the addition of antigen, and normal macrophages may become cytotoxic on binding immune complexes on their surface (Evans and Alexander, 1976) . A growing sarcoma, causing a continuous presence of circulating antigen or antigen-antibody complexes (Thomson et al., 1973) 
